Evaluation of Symptomatic Versus Asymptomatic Recurrences in Patients With Glioblastoma Multiforme (GBM)

被引：0
|
作者：
Altoos, B. [1 ]
Amini, A. [1 ]
Karam, S. [1 ]
Gaspar, L. E. [1 ]
Rusthoven, C. G. [1 ]
Waxweiler, T. V. [2 ]
Honce, J. [3 ]
Damek, D. M. [4 ]
Ney, D. E. [4 ]
Ormond, D. R. [5 ]
Lillehei, K. O. [5 ]
Kavanagh, B. D. [1 ]
Liu, A. K. [1 ]
机构：
[1] Univ Colorado Denver, Aurora, CO USA
[2] Univ Colorado, Aurora, CO USA
[3] Univ Colorado Denver, Dept Radiol, Aurora, CO USA
[4] Univ Colorado Denver, Dept Neurooncol, Aurora, CO USA
[5] Univ Colorado Denver, Dept Neurosurg, Aurora, CO USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2015年 / 93卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2015.07.846
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2298
引用
收藏
页码：E117 / E117
页数：1
相关论文
共 50 条
  • [1] Outcomes of symptomatic compared to asymptomatic recurrences in patients with glioblastoma multiforme (GBM)
    Amini, Arya
    Altoos, Basel
    Karam, Sana D.
    Waxweiler, Timothy V.
    Rusthoven, Chad G.
    Gaspar, Laurie E.
    Honce, Justin M.
    Damek, Denise M.
    Ney, Douglas E.
    Ormond, D. Ryan
    Lillehei, Kevin O.
    Chen, Changhu
    Kavanagh, Brian D.
    Liu, Arthur K.
    [J]. JOURNAL OF RADIATION ONCOLOGY, 2016, 5 (01) : 33 - 39
  • [2] Radiographic evaluation of recurrent glioblastoma multiforme (GBM) in patients treated with bevacizumab and irinotecan
    Andre, J.
    Spearman, K.
    Lu, S.
    Hwang, S.
    Dorsett, L.
    Raval, S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [3] Radiographic evaluation of recurrent glioblastoma multiforme (gbm) in patients treated with bevacizumab and irinotecan
    Andre, Jalal
    Spearman, Kenneth
    Lu, Stanley
    Raval, Sumul
    [J]. NEURO-ONCOLOGY, 2007, 9 (04) : 575 - 575
  • [4] Treatment patterns for patients with glioblastoma multiforme (GBM) in Germany
    Jenkins, A.
    Aristides, M.
    Liepa, A. M.
    Relf, C.
    Feilding, B.
    [J]. VALUE IN HEALTH, 2007, 10 (06) : A340 - A341
  • [5] MANAGEMENT OF GLIOBLASTOMA MULTIFORME RECURRENCES
    Kalita, O.
    Vaverka, M.
    Hrabalek, L.
    Houdek, M.
    Zlevorova, M.
    Tojanec, R.
    Hajduch, M.
    Ehrmann, J.
    Hlobikova, A.
    [J]. NEURO-ONCOLOGY, 2010, 12 : 51 - 51
  • [6] The prognostic significance of volumetry in patients with glioblastoma multiforme (GBM)
    Iliadis, G.
    Selviaridis, P.
    Kalogera-Fountzila, A.
    Fragkoulidi, A.
    Baltas, D.
    Misailidou, D.
    Zamboglou, N.
    Fountzilas, G.
    [J]. EJC SUPPLEMENTS, 2009, 7 (02): : 498 - 498
  • [7] PERSONALIZING DRUG SCREENING FOR GLIOBLASTOMA MULTIFORME (GBM) PATIENTS
    Jiang, Pengfei
    Chao, Ying
    Gallagher, Matthew
    Kim, Ryan
    Pastorino, Sandra
    Fogal, Valentina
    Kesari, Santosh
    [J]. NEURO-ONCOLOGY, 2011, 13 : 58 - 58
  • [8] Bevacizumab and irinotecan in patients with recurrent glioblastoma multiforme (GBM)
    Raval, Sumul N.
    Rule, Amy
    Hwang, Shirley S.
    [J]. NEURO-ONCOLOGY, 2006, 8 (04) : 482 - 482
  • [9] IMPACT OF GLIOBLASTOMA MULTIFORME (GBM) ON PATIENTS' QUALITY OF LIFE (QOL)
    Byrne, K.
    Waller, J.
    Piercy, J.
    Shaw, J.
    Dastani, H.
    [J]. NEURO-ONCOLOGY, 2017, 19 : 123 - 123
  • [10] Long-term survival of patients with glioblastoma multiforme (GBM)
    Smoll, Nicolas R.
    Schaller, Karl
    Gautschi, Oliver P.
    [J]. JOURNAL OF CLINICAL NEUROSCIENCE, 2013, 20 (05) : 670 - 675
12345